Table 3. Adverse Events in the Safety Population.
Variable | Study Participants, No. (%) | P Value | |
---|---|---|---|
Propranolol Group (n = 17) |
Steroid Group (n = 16) |
||
Adverse events | |||
Serious adverse event | 0 | 0 | |
Any adverse event | 16 (94) | 15 (94) | >.99a |
Known risks associated with drugsb | |||
Bradycardia | 0 | 0 | |
Hypotension | 5 (29) | 1 (7) | .18a |
Hypoglycemia | 0 | 0 | |
Trouble breathing | 0 | 0 | |
Gastroesophageal reflux | 0 | 0 | |
Hypertension | 7 (41) | 7 (47) | .75c |
Growth disability | 0 | 2 (13) | .21a |